Search company, investor...

Founded Year



Seed | Alive

About Podd

Podd offers a social business score for India, as a trust layer between merchants and consumers, tracking negative behaviors such as identity fraud, default and repetitive returns.

Headquarters Location

101, Leafy Blocks Owners Court Layout West

Karnataka, 560035,




Expert Collections containing Podd

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Podd is included in 1 Expert Collection, including Fintech.



12,502 items

Excludes US-based companies

Latest Podd News

Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

Oct 16, 2023

Woburn, Massachusetts, UNITED STATES WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today will present research demonstrating Comera’s SQore™ platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass. Yuhong Zeng, Ph.D., Director of Formulation at Comera, will present data from Comera’s SQore platform which is designed to transform intravenous biologics such as monoclonal antibodies (mAbs) into subcutaneous (SQ) formulations. Comera’s SQore platform has been successfully tested with over 40 mAbs, with viscosity reductions of up to 85%. Comera uses the SQore platform to identify the driving forces for high viscosity and select excipients that inhibit attractive protein-protein interactions to lower viscosity. Robert Mahoney, Ph.D., Chief Scientific Officer at Comera, commented, “The challenge many have faced with SQ delivery is that high-concentration antibody solutions can become viscous, and prone to physical instability, such as aggregation, precipitation, or denaturation. We have been able to successfully reduce the viscosity of a diverse range of monoclonal antibodies, demonstrating the versatility and remarkable capabilities of our SQore platform.” Comera is also presenting data from a preclinical study, previously published in the Journal of Pharmaceutical Sciences, that found that a caffeine excipient reduced viscosity of the monoclonal antibody ipilimumab without any adverse impact on antibody pharmacokinetic properties. The addition of one or more excipients, such as caffeine, selectively interrupts intermolecular interactions to reduce viscosity of high concentration mAb formulations. Dr. Mahoney continued, “The data reinforces the strength of our SQore platform in reformulating high-viscosity monoclonal antibody solutions and underscores the potential of caffeine and other core excipients as viscosity-reducing agents for subcutaneous monoclonal antibody formulations. Ultimately, the mission driving our research is to enhance convenience, decrease costs and increase compliance by reformulating therapies for patient-delivered SQ injections.” The presentation, titled “SQore™ Enabled High Concentration mAb Formulations for Patient-Delivered Subcutaneous Delivery,” can be accessed following the event at: . About Comera Life Sciences Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. To learn more about the Comera Life Sciences mission, as well as the proprietary SQore™ platform, visit . Forward-Looking Statements This press release includes “forward-looking statements” within the meaning of the federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events (including statements about the potential of our SQore platform) that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including, but not limited to: the Company’s ability to maintain the listing of its securities on the Nasdaq Capital Market; the price of the Company’s securities may be volatile due to a variety of factors, including changes in the competitive and highly regulated industries in which the Company plans to operate, variations in performance across competitors, changes in laws and regulations affecting the Company’s business and changes in the capital structure; the Company’s ability to execute on its business plans, forecasts, and other expectations and identify and realize additional opportunities; the risk of economic downturns and the possibility of rapid change in the highly competitive industry in which the Company operates; the risk that the Company and its current and future collaborators are unable to successfully develop and commercialize the Company’s products or services, or experience significant delays in doing so; the risk that we will be unable to continue to attract and retain third-party collaborators, including collaboration partners and licensors; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that the Company is unable to secure or protect its intellectual property; the risk that the Company is unable to secure regulatory approval for its product candidates; the effect of any resurgence of the COVID-19 pandemic or other public health emergencies on the Company’s business; general economic conditions; and other risks and uncertainties described in Item 1A of Part I of the Company’s Annual Report on Form 10-K filed with the SEC on March 17, 2023 under “Risk Factors” and in other filings that have been made or will be made with the SEC. The foregoing list of factors is not exhaustive. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Comera assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Comera can give no assurance that it will achieve its expectations. Contacts

Podd Frequently Asked Questions (FAQ)

  • When was Podd founded?

    Podd was founded in 2019.

  • Where is Podd's headquarters?

    Podd's headquarters is located at 101, Leafy Blocks, Karnataka.

  • What is Podd's latest funding round?

    Podd's latest funding round is Seed.

  • Who are the investors of Podd?

    Investors of Podd include SOSV.

  • Who are Podd's competitors?

    Competitors of Podd include MyShubhLife and 4 more.


Compare Podd to Competitors

CredoLab Logo

Credolab offers a smartphone and web behavioral data platform. Its pay-per-use solutions help banks, digital lenders, and ​book now pay later (BNPL) players, insurance companies, and more. The company was founded in 2016 and is based in Singapore, Singapore.


Eureka develops an artificial intelligence (AI) based omni-market and financial intelligence platform. It allows users to analyze, sort, and review information. It serves companies in industries including banking, insurance, transportation, and consumer goods. The company was founded in 2016 and is based in Singapore, Singapore.

Zest AI Logo
Zest AI

Zest AI provides artificial intelligence (AI)-driven credit underwriting software in the financial technology sector. The company offers a complete solution for lending, including the creation of custom machine-learning risk models, model assessment, regulatory compliance, performance management, and model monitoring. Zest AI primarily serves the lending segment of the economy, including banks, credit unions, and specialized lenders. It was founded in 2009 and is based in Burbank, California.

BankBazaar Logo

BankBazaar provides an online marketplace for users with customized rate quotes on loans and insurance products. It allows users to search for, compare and apply for loans, credit cards, and insurance products on the site. The company was founded in 2008 and is based in Chennai, India.

Lendingkart Logo

Lendingkart develops technology tools based on big data analysis which facilitates lenders to evaluate borrowers’ credit worthiness and provides other related services. It aims at bringing ease of financial assistance helping SMEs to address gaps in cash flows. Lendingkart was founded in 2014 and is based in Ahmedabad, India.

OfBusiness Logo

OfBusiness provides an online marketplace for business-to-business (B2B) commerce. The company sells products such as chemicals, steel, cement, agriculture, textile, solar, and more. It was founded in 2015 and is based in South Delhi, India.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.